메뉴 건너뛰기




Volumn 79, Issue 10, 2000, Pages 533-542

Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia

Author keywords

Acute myeloid leukemia; Cytosine arabinoside; Idarubicin; Induction therapy; Karyotype

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; IDARUBICIN;

EID: 0033794212     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000193     Document Type: Article
Times cited : (18)

References (33)
  • 1
    • 0005040904 scopus 로고    scopus 로고
    • A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group
    • (1998) Br J Haematol , vol.103 , pp. 100-109


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.